Berkshire Bank’s Gilead Sciences GILD Stock Holding History

Berkshire Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$486K	Hold	3,850	–	–	0.09%	112
2026 Q1	$537K	Hold	3,850	–	–	0.11%	102
2025 Q4	$473K	Sell	3,850 -66	-2%	-$8.02K	0.1%	105
2025 Q3	$435K	Sell	3,916 -146	-4%	-$16.6K	0.09%	106
2025 Q2	$450K	Buy	4,062 +285	+8%	+$30.3K	0.1%	104
2025 Q1	$423K	Buy	3,777 +379	+11%	+$39.1K	0.1%	110
2024 Q4	$314K	Buy	3,398 +111	+3%	+$9.99K	0.07%	123
2024 Q3	$276K	Buy	+3,287	New	+$251K	0.06%	131

Other funds holding GILD

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Berkshire Bank's GILD Position: Q2 2026 in Review

Berkshire Bank held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,850 shares worth $486K. The position accounts for 0.09% of the portfolio, ranked #112.

Berkshire Bank first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $537K in Q1 2026. 1,095 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Berkshire Bank held 3,850 shares of Gilead Sciences worth $486K as of Q2 2026.
Berkshire Bank left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.09% of Berkshire Bank's portfolio in Q2 2026, its #112 holding.
Berkshire Bank first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
Berkshire Bank's Gilead Sciences position peaked at $537K in Q1 2026.
1,095 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Berkshire Bank's 13F filing for Q2 2026, filed 8 Jul 2026.